Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/22/2008
 
First Published:
3/11/2008
1.
Phase II Study of Paricalcitol in Patients With Androgen-Refractory, Advanced Prostate Cancer With Bone Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Approved-not yet active
18 and over
NCI
CCCWFU-85107
CCCWFU 85107, NCT00634582
Last Modified:
5/2/2007
 
First Published:
9/16/2005
2.
Phase I Study of Paricalcitol and Gemcitabine in Patients With Advanced Malignancy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
RPCI-I-23204
ABBOTT-RPCI-I-23204, NCT00217477, I 23204
First Published:
11/18/2005
3.
Study of Paricalcitol and Zoledronate in Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
Pharmaceutical / Industry
RPCI-I-38504
NOVARTIS-RPCI-I-38504, ABBOTT-RPCI-I-38504, NCT00258258
First Published:
3/14/2008
4.
Study of Paricalcitol in Combination With Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Docetaxel, or Paclitaxel in Women With Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
18 and over
NCI
CCCWFU-74307
CCCWFU 74307, NCT00637897
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute